Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: The Women's Screening and Self-Testing Program (PROMETA) Study [NA]

View source ↗

Summary

The PROMETA clinical trial (NCT06810739) sponsored by Tulane University is studying therapies for HPV-related cervical cancer, and the study status is NOT_YET_R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tulane University | Conditions: Human Papilloma Virus Related Cervical Carcinoma | NA | Status: NOT_YET_RECRUITING